Primary sarcomas of the lung: a clinicopathological and immunohistochemical study of 14 cases

Histopathology. 1996 Jul;29(1):29-36. doi: 10.1046/j.1365-2559.1996.d01-481.x.


The clinicopathological features and immunohistochemical findings in 14 primary sarcomas of the lung collected over a 30-year-period are presented. This represents one sarcoma per 550 bronchogenic carcinomas undergoing resection in this centre. The study group comprised six leiomyosarcomas, five malignant peripheral nerve sheath tumours, two haemangiopericytomas and one epithelioid haemangioendothelioma. The majority of cases occurred in men (nine males: five females), with mean age at presentation of 54 years for men and 47 years for women. All leiomyosarcomas were seen in men, whereas malignant peripheral nerve sheath tumours showed no particular sex preponderance. Leiomyosarcomas were larger tumours than malignant peripheral nerve sheath tumours, mean tumour diameter 15 cm (range 10-25 cm) compared to 9.5 cm (7-15 cm), respectively. All leiomyosarcomas were situated intraparenchymally whereas two of the five malignant peripheral nerve sheath tumours were endobronchial in site. Extrathoracic metastates were seen at death in two of the six leiomyosarcomas but not in any of the malignant peripheral nerve sheath tumours. Overall survival was 28 months although for the leiomyosarcoma/malignant peripheral nerve sheath tumour group alone survival was 8 months. Tumour grading appeared to be a more useful prognostic factor than tumour site (endobronchial/parenchymal) or tumour size. Haemangiopericytoma and epithelioid haemangioendothelioma were associated with a more favourable prognosis.

MeSH terms

  • Adult
  • Aged
  • Female
  • Hemangioendothelioma, Epithelioid / immunology
  • Hemangioendothelioma, Epithelioid / pathology
  • Hemangiopericytoma / immunology
  • Hemangiopericytoma / pathology
  • Humans
  • Immunohistochemistry
  • Leiomyosarcoma / immunology
  • Leiomyosarcoma / pathology
  • Lung Neoplasms / immunology*
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Neurilemmoma / immunology
  • Neurilemmoma / pathology
  • Sarcoma / immunology*
  • Sarcoma / pathology*